cancer

Why do so many kids die so soon following a cancer diagnosis?While improvements have been made to childhood cancer mortality rates, a recent research study aims to identify how many children die before being able to start treatment, and what interventions can be put in place to improve their chances.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Why you need to pay attention to precision medicineDigital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.
Surprising link found in black women breast cancer riskAlcohol consumption is known to be a risk factor for breast cancer based on studies predominantly done in white women. Now, a University of North Carolina Lineberger Comprehensive Cancer Center study has found the same risk exists for black women.
Cancer Drug Spending SoarsNew therapies and increased awareness lead to a large market.
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Reimagineering chemotherapyFun isn’t what you’d typically expect in a chemotherapy infusion room. Yet, that’s precisely the environment an adolescent and young adult oncologist and a former Disney Imagineer created with the Infusionarium concept.
A First: Cancer Drug Is Approved on Genetic Basis, Not Tumor Location
A First: Cancer Drug Is Approved on Genetic Basis, Not Tumor LocationPembrolizumab gets FDA approval for cancers with a certain biomarker.
Endometriosis and cancer-driver mutationsA genomic analysis of endometriotic lesions shows that a disease associated with almost no risk of malignant transformation may harbor mutations associated with cancer. The findings, published in NEJM, provide a rationale for characterizing all endometriosis subtypes, say the authors.
Immuno-oncology bladder drug wins approvalSoon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.